Researchers at National Yang Ming Chiao Tung University (NYCU) who have developed a traditional Chinese medicine formula to suppress COVID-19 yesterday said that they plan to transfer the rights to the product on a non-profit basis.
The formula, known as “Jing Guan Fang,” contains weeping forsythia, Baikal skullcap, Chinese thorowax root, Magnolia officinalis bark and Korean mint, Hsu Chung-hua (許中華), a professor at NYCU’s Institute of Traditional Medicine, told a news conference, adding that it helps to suppress COVID-19 infection and symptoms.
The product was developed early in the COVID-19 pandemic, before vaccines became available, by drawing on knowledge from the SARS coronavirus, a close relative of SARS-CoV-2, which causes COVID-19, said Hsu, who is director of Taipei City Hospital’s Linsen Chinese Medicine and Kunming Branch.
Photo: Wu Po-hsuan, Taipei Times
Researchers from February to May 2020 conducted an initial study, distributing the product to frontline medical workers and hospital personnel, Hsu said.
Of the 1,086 people who took the formula, about 90 percent reported a reduction in sore throat, cough and other common cold symptoms, he said.
Based on the results, researchers at NYCU’s Institute of Traditional Medicine and Institute of Pharmacology conducted animal tests for the product, he said.
The formula “significantly reduced” the expression of two proteins in the lungs — ACE2 and TMRSS2 — which are receptors for SARS-CoV-2, thus impeding the process by which it binds to host cells, Hsu said.
The product was also effective when administered to laboratory mice as an inhalable drug, he added.
The formula is only available by prescription from doctors of Chinese medicine at public hospitals, Hsu said, adding that it should only be used as a supplement to COVID-19 vaccines.
By transferring the formula, a company could seek regulatory approval to make it available over-the-counter, thus allowing more people to access it, he said.
NYCU vice president Cheng Tzu-hao (鄭子豪) said that the university was looking for a manufacturer to whom it could transfer the rights to the formula on a charitable basis, citing the Oxford-AstraZeneca COVID-19 vaccine partnership as an example.
The NYCU team’s research was published on March 21 in the Frontiers in Pharmacology journal.
Taiwan has received more than US$70 million in royalties as of the end of last year from developing the F-16V jet as countries worldwide purchase or upgrade to this popular model, government and military officials said on Saturday. Taiwan funded the development of the F-16V jet and ended up the sole investor as other countries withdrew from the program. Now the F-16V is increasingly popular and countries must pay Taiwan a percentage in royalties when they purchase new F-16V aircraft or upgrade older F-16 models. The next five years are expected to be the peak for these royalties, with Taiwan potentially earning
STAY IN YOUR LANE: As the US and Israel attack Iran, the ministry has warned China not to overstep by including Taiwanese citizens in its evacuation orders The Ministry of Foreign Affairs (MOFA) yesterday rebuked a statement by China’s embassy in Israel that it would evacuate Taiwanese holders of Chinese travel documents from Israel amid the latter’s escalating conflict with Iran. Tensions have risen across the Middle East in the wake of US and Israeli airstrikes on Iran beginning Saturday. China subsequently issued an evacuation notice for its citizens. In a news release, the Chinese embassy in Israel said holders of “Taiwan compatriot permits (台胞證)” issued to Taiwanese nationals by Chinese authorities for travel to China — could register for evacuation to Egypt. In Taipei, the ministry yesterday said Taiwan
Taiwan is awaiting official notification from the US regarding the status of the Agreement on Reciprocal Trade (ART) after the US Supreme Court ruled US President Donald Trump's global tariffs unconstitutional. Speaking to reporters before a legislative hearing today, Premier Cho Jung-tai (卓榮泰) said that Taiwan's negotiation team remains focused on ensuring that the bilateral trade deal remains intact despite the legal challenge to Trump's tariff policy. "The US has pledged to notify its trade partners once the subsequent administrative and legal processes are finalized, and that certainly includes Taiwan," Cho said when asked about opposition parties’ doubts that the ART was
If China chose to invade Taiwan tomorrow, it would only have to sever three undersea fiber-optic cable clusters to cause a data blackout, Jason Hsu (許毓仁), a senior fellow at the Hudson Institute and former Chinese Nationalist Party (KMT) legislator, told a US security panel yesterday. In a Taiwan contingency, cable disruption would be one of the earliest preinvasion actions and the signal that escalation had begun, he said, adding that Taiwan’s current cable repair capabilities are insufficient. The US-China Economic and Security Review Commission (USCC) yesterday held a hearing on US-China Competition Under the Sea, with Hsu speaking on
RSS